This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
This interesting Guardian article discusses the fact that often, morbidity management in NTDs is overlooked, in favour of available drug treatment options and prevention. The reasons being given are mainly financial, with mass drug treatment being much less expensive than the more complex morbidity management options like surgery.